Hang Xie
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
AI-driven Chinese male facial skin phenotype profiling and its lifestyle correlation.
Journal: Scientific reports
Published: November 17, 2025
Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease Inhibitors.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 04, 2025
Identification of RIPK3 as a target of flavonoids for anti-necroptosis in vitro.
Journal: Bioorganic chemistry
Published: February 15, 2025
Enantiomeric meroterpenoids from Rhododendron capitatum and their anti-inflammatory activity.
Journal: Phytochemistry
Published: January 23, 2025
De novo design of protein condensation inhibitors by targeting an allosteric site of cGAS.
Journal: Nature communications
Published: September 20, 2024
An artificial intelligence powered study of enlarged facial pore prevalence on one million Chinese from different age groups and its correlation with environmental factors.
Journal: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
Published: August 08, 2024
Structure-based design of potent FABP4 inhibitors with high selectivity against FABP3.
Journal: European journal of medicinal chemistry
Published: October 07, 2023
Structure-based development of potent and selective type-II kinase inhibitors of RIPK1.
Journal: Acta pharmaceutica Sinica. B
Published: May 21, 2023
Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 24, 2022
Last Updated: 09/26/2026